NO951163L - Metode for antagonisering av inositol-1,4,5-trifosfat - Google Patents
Metode for antagonisering av inositol-1,4,5-trifosfatInfo
- Publication number
- NO951163L NO951163L NO951163A NO951163A NO951163L NO 951163 L NO951163 L NO 951163L NO 951163 A NO951163 A NO 951163A NO 951163 A NO951163 A NO 951163A NO 951163 L NO951163 L NO 951163L
- Authority
- NO
- Norway
- Prior art keywords
- antagonizing
- inositol
- triphosphate
- oligomers
- oligomer
- Prior art date
Links
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 title 1
- 230000003042 antagnostic effect Effects 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000006957 competitive inhibition Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polyurethanes Or Polyureas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95239392A | 1992-09-28 | 1992-09-28 | |
| PCT/US1993/008168 WO1994007507A1 (en) | 1992-09-28 | 1993-08-30 | Method for antagonizing inositol 1,4,5-triphosphate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO951163D0 NO951163D0 (no) | 1995-03-27 |
| NO951163L true NO951163L (no) | 1995-03-27 |
Family
ID=25492868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951163A NO951163L (no) | 1992-09-28 | 1995-03-27 | Metode for antagonisering av inositol-1,4,5-trifosfat |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0661982A1 (enExample) |
| JP (1) | JPH08502068A (enExample) |
| KR (1) | KR950703347A (enExample) |
| AU (1) | AU670962B2 (enExample) |
| CA (1) | CA2145681A1 (enExample) |
| HU (1) | HUT70192A (enExample) |
| IL (1) | IL107066A (enExample) |
| MX (1) | MX9305933A (enExample) |
| NO (1) | NO951163L (enExample) |
| NZ (1) | NZ256178A (enExample) |
| TW (1) | TW260663B (enExample) |
| WO (1) | WO1994007507A1 (enExample) |
| ZA (1) | ZA936978B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996000586A2 (en) * | 1994-06-30 | 1996-01-11 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Methods for treating cell proliferative disorders by modulating signal transduction |
| JPH11503110A (ja) * | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ−８受容体拮抗剤 |
| US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6083920A (en) * | 1995-12-21 | 2000-07-04 | Ayurcore, Inc. | Compositions for modulating intracellular inositol trisphosphate concentration |
| US6005008A (en) * | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6211373B1 (en) | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
| US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| WO1997049286A1 (en) | 1996-06-27 | 1997-12-31 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| CZ425598A3 (cs) * | 1996-06-27 | 1999-08-11 | Smithkline Beecham Corporation | Antagonista IL-8 receptoru |
| DE60127703D1 (de) * | 2000-11-09 | 2007-05-16 | Contrimmune Biotechnology Inc | Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion |
| JP2014531425A (ja) | 2011-09-02 | 2014-11-27 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | 肥満の代謝異常を治療するためのＣａＭＫＩＩ、ＩＰ３Ｒ、カルシニューリン、ｐ３８、およびＭＫ２／３阻害剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB781479A (en) * | 1953-08-27 | 1957-08-21 | Ciba Ltd | New polyureas and process for making them |
| US5276182A (en) * | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
-
1993
- 1993-08-30 KR KR1019950701166A patent/KR950703347A/ko not_active Ceased
- 1993-08-30 AU AU48417/93A patent/AU670962B2/en not_active Ceased
- 1993-08-30 HU HU9500891A patent/HUT70192A/hu unknown
- 1993-08-30 EP EP93921252A patent/EP0661982A1/en not_active Ceased
- 1993-08-30 JP JP6509054A patent/JPH08502068A/ja active Pending
- 1993-08-30 NZ NZ256178A patent/NZ256178A/en unknown
- 1993-08-30 CA CA002145681A patent/CA2145681A1/en not_active Abandoned
- 1993-08-30 WO PCT/US1993/008168 patent/WO1994007507A1/en not_active Ceased
- 1993-09-21 ZA ZA936978A patent/ZA936978B/xx unknown
- 1993-09-22 IL IL107066A patent/IL107066A/en not_active IP Right Cessation
- 1993-09-22 TW TW082107787A patent/TW260663B/zh active
- 1993-09-27 MX MX9305933A patent/MX9305933A/es unknown
-
1995
- 1995-03-27 NO NO951163A patent/NO951163L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2145681A1 (en) | 1994-04-14 |
| ZA936978B (en) | 1994-04-18 |
| KR950703347A (ko) | 1995-09-20 |
| NO951163D0 (no) | 1995-03-27 |
| AU4841793A (en) | 1994-04-26 |
| JPH08502068A (ja) | 1996-03-05 |
| TW260663B (enExample) | 1995-10-21 |
| WO1994007507A1 (en) | 1994-04-14 |
| MX9305933A (es) | 1994-04-29 |
| IL107066A0 (en) | 1993-12-28 |
| AU670962B2 (en) | 1996-08-08 |
| NZ256178A (en) | 1997-03-24 |
| EP0661982A1 (en) | 1995-07-12 |
| HU9500891D0 (en) | 1995-05-29 |
| IL107066A (en) | 1998-01-04 |
| HUT70192A (en) | 1995-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA26213C2 (uk) | Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові | |
| HUT62337A (en) | New cyclosporins, pharmaceutical compositions comprising such compounds and process for producing same | |
| AU1876788A (en) | Methylene phosphonoalkylphosphinates, pharmaceutical compositions , and methods for treating abnormal calcium and phosphate metabolism | |
| HU912359D0 (en) | The use of flupirtine active agents for treating muscle-tension | |
| EP0363415A4 (en) | Compounds for the treatment of alzheimer's disease | |
| EP0807633A3 (en) | Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones | |
| AU667593B2 (en) | Inhibitors of HIV protease useful for the treatment of AIDS | |
| NO952890L (no) | Kombinasjonsbehandling for inhibisjon av bentap | |
| HU910930D0 (en) | Process for the production of 2,8-dioxa-bicyclo/3.2.1/octane derivatives and medical preparations containing them | |
| NO902800L (no) | Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener. | |
| DE59204024D1 (de) | Verwendung von sulfatierten Oligosacchariden zur Behandlung arteriosklerotischer Erkrankungen und zur Verhinderung der Restenosierung. | |
| DK0701546T3 (da) | Aromatiske acetylchlolinesteraseinhibitorer | |
| FI102896B1 (fi) | Menetelmä farmaseuttisesti aktiivisen, rikkiä sisältävän heterosyklisen yhdisteen valmistamiseksi | |
| ZA887399B (en) | 4-aminopyridine derivatives | |
| EP0328634A4 (en) | Pharmaceutical compositions for the treatment of psoriasis | |
| MX9305933A (es) | Metodo para antagonizar al 1,4,5-trifosfato de inositol. | |
| EP0305181A3 (en) | Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin | |
| TW325997B (en) | Pharmaceutical composition for preventing and treating retinal diseases | |
| IL88740A0 (en) | Compositions for the inhibition of viruses | |
| HUT70757A (en) | Pharmaceutical compositions for treating skin disorders | |
| GR3034161T3 (en) | Pharmaceutical composition for preventing or treating. | |
| HUT55994A (en) | Process for producing pharmaceutical compositions for producing or inhibiting contraction of the pupil | |
| ATE88634T1 (de) | Arzneimittel zur behandlung von herzinsuffizienz. | |
| NO911237D0 (no) | Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og -kinolizidiner. | |
| ATE113843T1 (de) | Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids. |